Cargando…

Mini-PE, a prime editor with compact Cas9 and truncated reverse transcriptase

Prime editor (PE) is a versatile genome editing tool that does not need extra DNA donors or inducing double-strand breaks. However, in vivo implementation of PE remains a challenge because of its oversized composition. In this study, we screened out the smallest truncated Moloney murine leukemia vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Ting, Chen, Huangyao, Tang, Chengcheng, Wei, Yuhui, Liu, Yang, Zhou, Jizeng, Zhuang, Zhenpeng, Zhang, Quanjun, Chen, Min, Zhou, Xiaoqing, Chi, Yue, Wang, Jinling, He, Yu, Lai, Liangxue, Zou, Qingjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480570/
https://www.ncbi.nlm.nih.gov/pubmed/37680986
http://dx.doi.org/10.1016/j.omtn.2023.08.018
Descripción
Sumario:Prime editor (PE) is a versatile genome editing tool that does not need extra DNA donors or inducing double-strand breaks. However, in vivo implementation of PE remains a challenge because of its oversized composition. In this study, we screened out the smallest truncated Moloney murine leukemia virus (MMLV) reverse transcriptase (RT) with the F155Y mutation to keep gene editing efficiency. We discovered the most efficient gene editing variants of MMLV RT with the smallest size. After optimization of the pegRNAs and incorporation with nick sgRNAs, the mini-PE delivered up to 10% precise editing at target sites in human and mouse cells. It also edited the mouse Hsf1 gene in the mouse retina precisely after delivery with adeno-associated viruses (AAVs), although the editing efficiency was lower than 1%. We will focus on improving the editing efficiency of mini-PE and exploiting its therapeutic potential against human genetic diseases.